Food Security, Depression and Quality of Life in Northern Plains Indians

Major health disparities, high levels of poverty and food insecurity exist in many Native American and Alaskan Native (AI/AN) communities. Relatively little research has been done on these issues and possible relationships between them. A research program was designed with the objective of exploring the relationships between these various issues, if any existed, in one sub-group of AI/AN. In the study, the incidence of food insecurity was determined in a convenience sample of Northern Plains Indians (NPI) and correlated with measures of physical and mental health, body composition, quality of life, cultural identification and dietary intakes. Participants were 458 adult attendees at summer powwows and health fairs held at 5 reservations and 3 tribal colleges in North Dakota and western Minnesota. Participants completed various measurements and assessments and pertinent health and demographic data were recorded. Observed incidences of “food insecurity” overall and “very low food security” in particular (26.4% and 10.4%, respectively) were in sharp contrast to recently reported rates for North Dakota (8.7% and 3.4%) and the U.S. population as a whole (14.7% and 5.6%). In this manuscript, analysis revealed a positive relationship between food insecurity and depression and a negative relationship between food insecurity and quality of life. The findings emphasize the need to address food insecurity when designing research and service programs to address depression in AI/AN populations

Nutrient composition of selected traditional United States Northern Plains Native American plant foods

Ten wild plants (cattail broad leaf shoots, chokecherries, beaked hazelnuts, lambsquarters, plains prickly pear, prairie turnips, stinging nettles, wild plums, raspberries, and rose hips) from three Native American reservations in North Dakota were analyzed to expand composition information of traditional foraged plants. Proximates, dietary fiber (DF), vitamins, minerals, carotenoids, and folate vitamers were assayed using standard methods and reference materials. Per serving, all were rich in Mn (100–2808 mg). Several provided \u3e10% DRI of Fe (cattail shoots, steamed lambsquarters, and prairie turnips), Ca (steamed lambsquarters, prickly pear, and prairie turnips), Mg (cattail shoots, lambsquarters, prickly pear, and prairie turnips), vitamins B6 (chokecherries, steamed lambsquarters, broiled prickly pear, and prairie turnips), C (raw prickly pear, plums, raspberries, rose hips (426 mg/100 g), and K (cattail shoots, chokecherries, lambsquarters, plums, rose hips, and stinging nettles). DF was \u3e10 g/serving in chokecherries, prairie turnips, plums and raspberries. Rose hips, plums, lambsquarters, and stinging nettles were carotenoid-rich (total, 3.2–11.7 mg/100 g; b-carotene, 1.2–2.4 mg/100 g; lutein/zeaxan- thin, 0.9–6.2 mg/100 g) and lycopene (rose hips only, 6.8 mg/100 g). Folate (primarily 5-methylte- trahydrofolate) was highest in raw lambsquarters (97.5 mg/100 g) and notable in cattail shoots, raw prairie turnips, and blanched stinging nettles (10.8, 11.5, and 24.0 mg/100 g, respectively). Results, provided to collaborating tribes and available in the National Nutrient Database of the United States Department of Agriculture (USDA) (www.ars.usda.gov/nutrientdata), support reintroduction or increased consumption of foraged plants

Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV- Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial

Background: Recombinant human growth hormone (rhGH) reduces visceral adipose tissue (VAT) volume in HIV-infected patients but can worsen glucose homeostasis and lipoatrophy. We aimed to determine if adding rosiglitazone to rhGH would abrogate the adverse effects of rhGH on insulin sensitivity (SI) and subcutaneous adipose tissue (SAT) volume. Methodology/Principal Findings: Randomized, double-blind, placebo-controlled, multicenter trial using a 262 factorial design in which HIV-infected subjects with abdominal obesity and insulin resistance were randomized to rhGH 3 mg daily, rosiglitazone 4 mg twice daily, combination rhGH + rosiglitazone, or double placebo (control) for 12 weeks. The primary endpoint was change in SI by frequently sampled intravenous glucose tolerance test from entry to week 12. Body composition was assessed by whole body magnetic resonance imaging (MRI) and dual Xray absorptiometry (DEXA). Seventy-seven subjects were randomized of whom 72 initiated study drugs. Change in SI from entry to week 12 differed across the 4 arms by 1-way ANCOVA (P = 0.02); by pair-wise comparisons, only rhGH (decreasing SI; P = 0.03) differed significantly from control. Changes from entry to week 12 in fasting glucose and glucose area under the curve on 2- hour oral glucose tolerance test differed across arms (1-way ANCOVA P = 0.004), increasing in the rhGH arm relative to control. VAT decreased significantly in the rhGH arms (217.5% in rhGH/rosiglitazone and 222.7% in rhGH) but not in the rosiglitazone alone (22.5%) or control arms (21.9%). SAT did not change significantly in any arm. DEXA results were consistent with the MRI data. There was no significant rhGH x rosiglitazone interaction for any body composition parameter. Conclusions/Significance: The addition of rosiglitazone abrogated the adverse effects of rhGH on insulin sensitivity and glucose tolerance while not significantly modifying the lowering effect of rhGH on VAT